Two nationally recognized scientists with decades of experience advising U.S. vaccine policy argue that it is a mistake to exclude well-designed observational studies in determining how well vaccines work on a year-to-year basis.
Michigan Public Health faculty and researchers advance digital health research, examine global school feeding programs, and share expertise on healthcare spending, noise pollution, and the power of public health storytelling.
One dose of the antiviral baloxavir marboxil lowers the chance of transmitting the influenza virus to family members by about 30%, according to new research in the New England Journal of Medicine from University of Michigan researchers.
US flu vaccines are likely to move from quadrivalent to trivalent due to a change in circulating influenza viruses, says University of Michigan School of Public Health researcher Arnold Monto.
The Food and Drug Administration’s expert vaccine advisory panel on Thursday unanimously endorsed the idea of taking a strain of influenza viruses that no longer appears to circulate out of flu shots as quickly as possible, pressing the FDA and manufacturers to try to get the work done on an expedited timeline.
The University of Michigan School of Public Health is among 13 institutions that will receive funding from the Centers for Disease Control and Prevention as part of a network of centers focused on predicting and preparing for future disease outbreaks.